<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[MRC Medical]]></title><description><![CDATA[MRC Medical]]></description><link>https://www.mrcmedical.net/blog</link><generator>RSS for Node</generator><lastBuildDate>Tue, 06 Oct 2026 04:41:29 GMT</lastBuildDate><atom:link href="https://www.mrcmedical.net/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Is Your Medtech Market Strategy Ready Before FDA Authorization]]></title><description><![CDATA[An FDA submission can feel like the finish line. For many medtech companies, it becomes the center of gravity for months or years: test data, labeling, technical files, reviewer questions, quality documentation, and the next regulatory milestone. But authorization alone does not create market adoption. A device can clear a regulatory path and still struggle to gain clinical use, payer interest, sales traction, or investor confidence. The gap is rarely caused by one missed tactic. It often...]]></description><link>https://www.mrcmedical.net/post/is-your-medtech-market-strategy-ready-before-fda-authorization</link><guid isPermaLink="false">6ac450bb10d33c5bea352e32</guid><pubDate>Tue, 06 Oct 2026 01:38:39 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/d53f11_13a30f58fca2436995936ff67b810b35~mv2.png/v1/fit/w_1000,h_896,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Dave Rector</dc:creator></item></channel></rss>